Literature DB >> 23924497

Programmed death 1 and programmed death ligand 1 expressions in patients with chronic hepatitis B.

Wen-Jin Zhang1, Chuan-Hui Peng, Shu-Sen Zheng.   

Abstract

BACKGROUND: The role of programmed death 1 (PD-1) and programmed death ligand 1 (PD-L1) in persistent HBV infection is controversial. Increasing PD-1 and PD-L1 expression has been found in hepatitis B patients during immune clearance phase, but not in HBV-tolerant patients. We investigated PD-1 and PD-L1 expression and inflammation in chronic hepatitis B.
METHODS: Twenty patients with chronic hepatitis B participated in this study. Fifteen patients were in the immune clearance phase, and 5 were in the immune inactive phase. Circulating HBV-specific T cells were analyzed by flow cytometric detection of major histocompatibility complex (MHC) class I peptide complexes, known as pentamers. Intra-hepatic PD-1 and PD-L1 expressions were analyzed by immunostaining.
RESULTS: The frequency of pentamers, including core 18-27 (1.88%+/-0.36%), env 335-343 (1.85%+/-0.37%), and pol 575-583 (1.56%+/-0.29%) was 8.30-, 7.71- and 8.48-fold greater during immune clearance phase than those during the immune inactive phase. In addition, more than 70% of circulating pentamers were PD-1 positive. During immune clearance phase, the numbers of intra-hepatic PD-1 and PD-L1 positive cells were 108+/-23/HPF and 97+/-20/HPF respectively, in contrast, there was a paucity of PD-1 and PD-L1 positive cells in the immune inactive phase. The numbers of intra-hepatic PD-1 and PD-L1 positive cells were positively correlated with serum alanine aminotransferase and the number of intra-hepatic CD8+ T cells. Immunofluorescence showed that almost all of the intra-hepatic CD8+ T cells were PD-1 and CCR6 positive. These cells aggregated around macrophage inflammatory protein-3 alpha (MIP3alpha) positive cells and mixed with PD-L1 positive cells.
CONCLUSIONS: PD-1 and PD-L1 expressions were significantly correlated with inflammation. CCR6 and PD-1 co-expressed in the same cells; these cells were increased both in circulation and the inflamed liver and aggregated around MIP3alpha positive cells. The mixture of CCR6 and PD-1, MIP3alpha and PD-L1 positive cells created immune response compartments which played an important role in specific immune response in HBV immune clearance.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23924497     DOI: 10.1016/s1499-3872(13)60061-2

Source DB:  PubMed          Journal:  Hepatobiliary Pancreat Dis Int


  6 in total

Review 1.  Chronic hepatitis B: A wave of new therapies on the horizon.

Authors:  Timothy M Block; Siddhartha Rawat; Carol L Brosgart
Journal:  Antiviral Res       Date:  2015-06-22       Impact factor: 5.970

2.  Immune checkpoint proteins PD-1 and TIM-3 are both highly expressed in liver tissues and correlate with their gene polymorphisms in patients with HBV-related hepatocellular carcinoma.

Authors:  Zhu Li; Na Li; Fang Li; Zhihua Zhou; Jiao Sang; Yanping Chen; Qunying Han; Yi Lv; Zhengwen Liu
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.889

3.  Circulating soluble programmed death-1 levels may differentiate immune-tolerant phase from other phases and hepatocellular carcinoma from other clinical diseases in chronic hepatitis B virus infection.

Authors:  Na Li; Zhihua Zhou; Fang Li; Jiao Sang; Qunying Han; Yi Lv; Wenxuan Zhao; Chunyan Li; Zhengwen Liu
Journal:  Oncotarget       Date:  2017-07-11

4.  Safety and efficacy of anti-PD-L1 therapy in the woodchuck model of HBV infection.

Authors:  Scott Balsitis; Volodymyr Gali; Pamela J Mason; Susan Chaniewski; Steven M Levine; Michael J Wichroski; Michael Feulner; Yunling Song; Karen Granaldi; James K Loy; Chris M Thompson; Jacob A Lesniak; Catherine Brockus; Narendra Kishnani; Stephan Menne; Mark I Cockett; Renuka Iyer; Stephen W Mason; Daniel J Tenney
Journal:  PLoS One       Date:  2018-02-14       Impact factor: 3.240

5.  Adaptive and Innate Immune Cells in Fetal Human Cytomegalovirus-Infected Brains.

Authors:  Yann Sellier; Florence Marliot; Bettina Bessières; Julien Stirnemann; Ferechte Encha-Razavi; Tiffany Guilleminot; Nacilla Haicheur; Franck Pages; Yves Ville; Marianne Leruez-Ville
Journal:  Microorganisms       Date:  2020-01-25

6.  Highly elevated soluble Tim-3 levels correlate with increased hepatocellular carcinoma risk and poor survival of hepatocellular carcinoma patients in chronic hepatitis B virus infection.

Authors:  Fang Li; Na Li; Jiao Sang; Xiude Fan; Huan Deng; Xiaoge Zhang; Qunying Han; Yi Lv; Zhengwen Liu
Journal:  Cancer Manag Res       Date:  2018-05-01       Impact factor: 3.989

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.